KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baker Hughes (BKR) Cash & Equivalents (2016 - 2025)

Baker Hughes (BKR) has disclosed Cash & Equivalents for 10 consecutive years, with $3.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 10.43% year-over-year to $3.7 billion, compared with a TTM value of $3.7 billion through Dec 2025, up 10.43%, and an annual FY2025 reading of $3.7 billion, up 10.43% over the prior year.
  • Cash & Equivalents was $3.7 billion for Q4 2025 at Baker Hughes, up from $2.7 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.4 billion in Q1 2021 and bottomed at $2.3 billion in Q2 2024.
  • Average Cash & Equivalents over 5 years is $3.1 billion, with a median of $3.0 billion recorded in 2022.
  • The sharpest move saw Cash & Equivalents soared 45.58% in 2021, then crashed 35.43% in 2022.
  • Year by year, Cash & Equivalents stood at $3.9 billion in 2021, then tumbled by 35.43% to $2.5 billion in 2022, then increased by 6.35% to $2.6 billion in 2023, then grew by 27.14% to $3.4 billion in 2024, then grew by 10.43% to $3.7 billion in 2025.
  • Business Quant data shows Cash & Equivalents for BKR at $3.7 billion in Q4 2025, $2.7 billion in Q3 2025, and $3.1 billion in Q2 2025.